LongRiver Investments

We Built

Our Foundation with Leading Global Institutions

Backed by leading global financial institutions and top-tier asset managers

One of the largest emerging venture capital vehicles in recent years

We Back

the Next Generation of Industry Leaders

Driving innovation and growth in healthcare and technology

Capital, expertise and networks

We Manage

the Full Investment Cycle, from Sourcing to Exit

Source

Identify and incubate opportunities early through a top-down research framework

Collaborate closely with industry leaders and KOLs

Invest

10+ years focused on healthcare and deep tech

80+ investments across global markets, including pre-fund track record

Scale

Support companies from early-stage growth to IPO readiness

Provide hands-on support in strategy, financing, partnerships, and global expansion

Exit

20+ exits across IPOs and M&A, including pre-fund track record

Proven experience navigating global capital markets

We Believe

Three Things Matter Most

Accountability

We earn the trust of our LPs, stand with entrepreneurs, and hold ourselves accountable every step of the way.

Excellence

We do the right thing for the long term. We stay sharp and create value that lasts.

Entrepreneurship

We learn, adapt, and grow. We don't chase trends; we build the edge that sets us apart.

News & Insights

LongRiver Portfolio company Ouro Medicines Enters into Definitive Agreement to be Acquired by Gilead Sciences

LongRiver portfolio company, Ouro Medicines, has entered into a definitive agreement to be acquired by Gilead Sciences.

24.03.2026

News & Insights